Pharmaforce Reports Private Limited, a active foreign private limited company, was established on 02 May 2013 in Pune, Maharashtra, India. Engaging in pharma contract r&d within the professional, scientific and technical sector, it holds CIN: U74900PN2013FTC147209. Registered under ROC Roc Pune. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Llena Vijay Samant (Director), Tom Nordhoy (Director), Snehal Sahadev Patil (Additional Director). Past directors included Richa Amit Jha, Snehal Sahadev Patil, Neeta Satish Pradhan. Its latest AGM occurred on 30 September 2019, with the balance sheet filed on 31 March 2019. It is based at C/Oflexisales,Groundfloor,A-Wing,Unitno.2Businessmantripark,Vimannagar, Pune, Maharashtra, 411014.
U74900PN2013FTC147209
147209
02 May 2013
₹0.50 M
₹0.10 M
Roc Pune
Unlisted
Active
Explore comprehensive insights into Pharmaforce Reports Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Llena Vijay Samant | Director | 02 May 2013 | Current |
| Tom Nordhoy | Director | 02 May 2013 | Current |
| Snehal Sahadev Patil | Additional Director | 26 Apr 2021 | Current |
| Asit Sharma | Director | 18 Apr 2019 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 26 Apr 2015 | Past |
| Pramod Abcsdd | Additional Director | 07 Jan 2022 | Past |
| Pramod Abcsdd | Director | 15 Mar 2018 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2019 | Past |
| Pramod Abcsdd | Director | 20 Jan 2020 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Pharmaforce Reports Private Limited, for the financial year ended 2019, experienced significant reduction in revenue, with a 14.68% decrease. The company also saw a slight improvement in profitability, with a 9.14% increase in profit. The company's net worth Soared by an impressive increase of 53.79%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2019, Pharmaforce Reports had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Pharmaforce Reports, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Pharmaforce Reports, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pharmaforce Reports's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Snehal Sahadev Patil was appointed as a Additional Director was appointed as a Additional Director on 26 Apr 2021 & has been associated with this company since 4 years 7 months . was completed.
Pharmaforce Reports Private Limited last Annual general meeting of members was held on 30 Sep 2019 as per latest MCA records. was recorded as a recent event.
The activity Asit Sharma was appointed as a Director was appointed as a Director on 18 Apr 2019 & has been associated with this company since 6 years 7 months . was completed.
Pharmaforce Reports Private Limited has filed its annual Financial statements for the year ended 31 Mar 2019 with Roc Pune. was recorded as a recent event.
Llena Vijay Samant was appointed as a Director was appointed as a Director on 02 May 2013 & has been associated with this company since 12 years 6 months . was recorded as a recent event.
The activity Tom Nordhoy was appointed as a Director was appointed as a Director on 02 May 2013 & has been associated with this company since 12 years 6 months . was completed.
The CIN of Pharmaforce Reports Private Limited is U74900PN2013FTC147209.
Pharmaforce Reports Private Limited is headquartered at C/Oflexisales,Groundfloor,A-Wing,Unitno.2Businessmantripark,Vimannagar, Pune, Maharashtra, 411014.
Pharmaforce Reports Private Limited was incorporated on 02 May 2013.
The current directors of Pharmaforce Reports Private Limited are
The primary industry of Pharmaforce Reports Private Limited is Professional, Scientific And Technical.
Pharmaforce Reports Private Limited is unlisted.
The authorized capital of Pharmaforce Reports Private Limited is ₹0.50 M, and the paid-up capital is ₹0.10 M.
The compliance status of Pharmaforce Reports Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX